|
Re: Long Covid remains a big challenge
|
2
|
Resverlogix Corp.
|
Jul 26, 2023 12:02PM
|
|
Re: Contest
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 04:50PM
|
|
Re: Hate to say it here first
|
2
|
Resverlogix Corp.
|
Sep 29, 2019 11:53PM
|
|
Re: Venue for the celebration
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 05:37PM
|
|
Re: BOM 2 Trial
|
2
|
Resverlogix Corp.
|
Jun 10, 2020 12:56PM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 10, 2023 01:49PM
|
|
Re: Wonder what the big investors think currently
|
2
|
Resverlogix Corp.
|
Dec 01, 2023 09:10PM
|
|
Re: 2 year extension
|
2
|
Resverlogix Corp.
|
May 14, 2024 11:16AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Apr 01, 2020 01:28PM
|
|
Re: Breakthrough Therapy Question
|
2
|
Resverlogix Corp.
|
Jan 06, 2020 05:13PM
|
|
Re: Clarification on BETonMACE baseline data
|
2
|
Resverlogix Corp.
|
Sep 06, 2019 08:07AM
|
|
Re: Rumors....
|
2
|
Resverlogix Corp.
|
Nov 21, 2019 11:47AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
2
|
Resverlogix Corp.
|
Dec 22, 2020 09:58AM
|
|
Re: Today's stream - link
|
2
|
Resverlogix Corp.
|
Sep 10, 2020 02:11PM
|
|
Re: What's the deal with Zenith?
|
2
|
Zenith Epigenetics
|
Jun 23, 2023 11:18AM
|
|
Re: Biotech Showcase, Jan 13-15
|
2
|
Resverlogix Corp.
|
Jan 12, 2020 11:38AM
|
|
Re: Saudi
|
2
|
Resverlogix Corp.
|
Jan 15, 2021 01:27PM
|
|
Re: Booyah ! I told you all!!
|
2
|
Resverlogix Corp.
|
May 15, 2019 09:56AM
|
|
Re: Diving into....
|
2
|
Resverlogix Corp.
|
Sep 28, 2019 10:12AM
|
|
Re: Down 53% today
|
2
|
Zenith Epigenetics
|
Jun 08, 2023 09:38AM
|
